Increased Expression of CD69 Antigen on Human Peripheral Blood Natural Killer Cells in Patients with Allergic Rhinitis
-
Mozafar Mohammadi Nejad
,
Eisa Salehi
,
Mehrnaz Mesdaghi
,
Lida Atarod
,
Masoud Movahedi
,
Zahra Gheflati
,
Tahereh Aboufazeli
,
Mohammad Vodjgani
Abstract
Allergic rhinitis (AR) is an inflammatory disorder of the nasal mucosa with high morbidity and prevalence. Natural killer (NK) cells might have a role in AR. We aimed to evaluate the changes of the markers and receptors on NK cells in AR patients compared to the non-atopic controls.
Flow cytometric analysis was used with double staining of the Peripheral Blood Mononuclear Cells (PBMCs) to examine the expression of CD25 and CD69 markers, and NKG2D and NKG2A receptors on NK cells of 20 patients with AR and 20 non-atopic controls. The serum total IgE level was measured by Enzyme-linked Immunosorbent Assay.
The expression of CD69 antigen on NK cells in AR patients was significantly higher than that of healthy group (p=0.03). No significant changes were observed between CD25, NKG2D and NKG2A expression on the surface of NK cells from healthy and AR subjects. Our study also showed that there was no significant correlation between the expression of CD69, CD25, NKG2D and NKG2A and level of serum total IgE in AR patients and normal subjects.
These results indicated that the expression of CD69 antigen on NK cells of AR patients was increased. The high expression of CD69 on NK cells in AR patients suggested that these cells were activated, probably due to the cytokines secreted from allergen-stimulated T cells and activated monocytes.
1. Bousquet J. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 Update (in collaboration with the World Health Organization, GA2LEN and AllerGen). Allergy 2008; 63(Suppl 86):160-8.
2. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol 2007; 19:23-34.
3. Howarth PH. The cellular basis for allergic rhinitis. Allergy 1995; 50(23 Supple):6-10.
4. Moretta L, Moretta A. Killer immunoglobulin-like receptors. CurrOpinImmunol 2004; 16(5):626–33.
5. Moretta L, Biassoni R, Bottino C, Cantoni C, Pende D,Mingari MC, et al. Human NK cells and their receptors. Microbes Infect 2002; 4(15):1539–44.
6. Farag SS, Fehniger TA, Ruggeri L, Velardi A, Caligiuri MA. Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 2002; 100(6):1935-47.
7.Kruszewski J, Janiak M, Romanowska E, Maleszka P.Activity of natural killer cells (NK) in patients with atopic diseases of the respiratory system. PneumonolAlergo Pol 1991; 59(1-2):38-42.
8. Mesdaghi M, Vodjgani M, Salehi E, Hadjati J, Sarrafnejad A, Bidad K, et al. Natural killer cells in allergic rhinitis patients and nonatopic controls.Int Arch Allergy Immunol 2010; 153(3):234-8.
9. Santis AG, López-Cabrera M, Hamann J, Strauss M, Sánchez-Madrid F. Structure of the gene coding for the human early lymphocyte activation antigen CD69: a C- type lectin receptor evolutionarily related with the gene families of natural killer cell-specific receptors. Eur J Immunol 1994; 24(7):1692-7.
10. Llera AS, Viedma F, Sanchez-Madrid F, Tormo J. Crystal structure of the C-type lectin-like domain from the human hematopoietic cell receptor CD69. J BiolChem 2001;276(10):7312-9.
11. Sánchez-Mateos P, Cebrián M, Acevedo A, López-Botet M, De Landázuri MO, Sánchez-Madrid F. Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues.Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies. Immunology 1989; 68(1):72-9.
12. Clausen J, Vergeiner B, Enk M, Petzer AL, Gastl G, Gunsilius E. Functional significance of the activation- associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells. Immunobiology 2003; 207(2):85-93.
13.Takizawa K, Kitani S, Takeuchi F, Yamamoto K.Enhanced Expression of CD69 and CD25 Antigen on Human Peripheral Blood Mononuclear Cells by Prolactin. Endocr J 2005;52(5):635-41.
14. Montoro J, Sastre J, Jáuregui I, Bartra J, Dávila I, del Cuvillo A, et al. Allergic rhinitis: continuous or on demand antihistamine therapy? J Investig Allergol Clin Immunol 2007; 17 (Suppl 2):21-7.
15. Rondón C, Fernandez J, Canto G, Blanca M. Local allergic rhinitis: concept, clinical manifestations, and diagnostic approach. J Investig Allergol Clin Immunol 2010; 20(5):364-71.
16. Linneberg A, Nielsen NH, Madsen F, Frolund L, Dirksen A, Jorgensen T. Increasing prevalence of allergic rhinitis symptomsin an adult Danish population Allergy 1999; 54(11):1194-8.
17. Fokkens WJ. Thoughts on the pathophysiology of nonallergic rhinitis.Curr Allergy Asthma Rep 2002;2(3):203-9.
18. Tharwat E. Deraz. Immunopathogenesis of allergic rhinitis. Egypt J Pediatr Allergy Immunol 2010; 8(1):3-7.
19. Rihoux JP. Perennial allergic rhinitis and keratoconjunctivitis. Thorax 2000; 55 (Suppl 2):S22-3.
20. Rola-Pleszczynski M, Gagnon L, Sirois P. Leukotriene B4 augments human natural cytotoxic cell activity. BiochemBiophys Res Commun 1983; 113(2):531-7.
21. Liu A, Claesson HE, Mahshid Y, Klein G, Klein E.Leukotriene B4 activates T cells that inhibit B-cell proliferation in EBV-infected cord blood–derived mononuclear cell cultures. Blood 2008; 111(5):2693-703.
22. J Stanková, N Gagnon, M Rola-Pleszczynski. Leukotriene B4 augments interleukin-2 receptor-beta (IL-2Rβ) expression and IL-2Rf-mediated cytotoxic response in humanperipheral blood lymphocytes. Immunology 1992;76(2):258-63.
23. Siegel JP, Sharon M, Smith PL, Leonard WJ. The IL-2 receptor beta chain (p70): role in mediating signals for LAK, NK, and proliferative activities. Science 1987;238(4823):75-8.
24. Sancho D, Gomez M, Sanchez-Madrid F.CD69 is an immunoregulatory molecule induced following activation. Trends in Immunology 2005; 26(3):136-40.
25. Laffo´n A, Garcia-Vicun˜a R, Humbria A, PostigoA, Corbi A, LdeLandazuri MO, et al. Upregulated expression and function of VLA-4 fibronectin receptors on human activated T cells in rheumatoid arthritis. J Clin Invest 1991; 88(2):546-52.
26. Garcı´a-Monzo´n C, Moreno-Otero R, Pajares J M, Garcı´a-Sa´nchez A, Lo´pez-Botet M, de Landazuri M O, et al. Expression of a novel activation antigen on intrahepatic CD8+ T lymphocytes in viral chronic active hepatitis. Gastroenterology 1990; 98(4):1029-35.
27. Marzio R, Mauel J, Betz-Corradin S. CD69 and regulation of the immune function. ImmunopharmacolImmunotoxicol 1999; 21(3):565-82.
28. Gołebiowska-Wawrzyniak M, Markiewicz K, Rytwiński K, Buława E, Czerwińska I, Wnuk A, et al. CD69 and PCNA expression of T-lymphocytes from children with cow's milk allergy (CMA). Med WiekuRozwoj 2003; 7(4Pt 2):565-75.
29. Wang Zhaoyan, Kong Fanrong, Guo Shaolei. The expression and significance of CD69 on T lymphocyte in systemic lupus erythematosus patients. Medical Laboratory Science and Clinics 2007; 05.
30. Brauner H, Elemans M, Lemos S, Broberger C, Holmberg D, Flodström-Tullberg M, et al. Distinct phenotype and function of NK cells in the pancreas of nonobese diabetic mice. J Immunol 2010; 184(5):2272-80
31. Miki-Hosokawa T, Hasegawa A, Iwamura C, Shinoda K,Tofukuji S, Watanabe Y, et al. CD69 controls the pathogenesis of allergic airway inflammation. J Immunol 2009; 183(12):8203-15.
32. Craston R, Koh M, McDermott A, Ray N, Prentice HG,Lowdell MW. Temporal dynamics of CD69 expression on lymphoid cells. J Immunol Methods 1997;209(1):37-45.
33. Werfel T, Boeker M, Kapp A. Rapid expression of the CD69 antigen on T cells and natural killer cells upon antigenic stimulation of peripheral blood mononuclear cell suspensions. Allergy 1997; 52(4):465-9.
34. Borrego F, Robertson MJ, Ritz J, Peña J, Solana R. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor. Immunology 1999; 97(1):159-65.
| Files | ||
| Issue | Vol 12, No 1 (2013) | |
| Section | Articles | |
| Keywords | ||
| Allergic rhinitis CD69 antigen Natural killer cell | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
